Versor Investments’s NeoGenomics NEO Stock Holding History

Versor Investments’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-49,270	Closed	-$455K	–	828
2022 Q4	$455K	Buy	49,270 +20,203	+70%	+$188K	0.04%	373
2022 Q3	$250K	Buy	+29,067	New	+$289K	0.01%	664
2021 Q4	–	Sell	-7,792	Closed	-$376K	–	615
2021 Q3	$376K	Buy	+7,792	New	+$361K	0.01%	326
2019 Q4	–	Sell	-38,500	Closed	-$736K	–	349
2019 Q3	$736K	Buy	+38,500	New	+$903K	0.05%	188

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Versor Investments's NEO Position: Q1 2023 in Review

Versor Investments sold out of NeoGenomics (NEO) in Q1 2023, closing a stake of 49,270 shares — an estimated $455K sold.

Versor Investments first reported a position in NEO in Q3 2019 and held it in 4 quarters. The position peaked at $736K in Q3 2019. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2023.

Versor Investments reported no remaining NeoGenomics position as of Q1 2023 after selling out during the quarter.
Versor Investments sold 49,270 NeoGenomics shares in Q1 2023, an estimated $455K.
Versor Investments first reported a position in NeoGenomics in Q3 2019 and held it in 4 quarters.
Versor Investments's NeoGenomics position peaked at $736K in Q3 2019.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2023.

Based on Versor Investments's 13F filing for Q1 2023, filed 5 May 2023.